Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.

Item

http://www.wikidata.org/entity/Q38627432

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.

@en

type

Item

label

Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.

@en

prefLabel

Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.

@en

P1476

Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.

@en

P2093

Aaron K Aragaki

http://www.w3.org/2001/XMLSchema#string

Ross Prentice

http://www.w3.org/2001/XMLSchema#string

Rowan T Chlebowski

http://www.w3.org/2001/XMLSchema#string

P2860

Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010-2011).

Association between polymorphisms in glutathione peroxidase and selenoprotein P genes, glutathione peroxidase activity, HRT use and breast cancer risk

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

Interactive effect of genetic susceptibility with height, body mass index, and hormone replacement therapy on the risk of breast cancer.

Breast cancer risk in relation to the interval between menopause and starting hormone therapy.

Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant.

P31

scholarly article

meta-analysis

P356

10.1093/JNCI/DJV327

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Garnet L Anderson

P577

2015-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26546117

http://www.w3.org/2001/XMLSchema#string

P932

5943827

http://www.w3.org/2001/XMLSchema#string